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a b s t r a c t
H7 avian inﬂuenza viruses (AIVs) have caused a number of human infections, highlighting the pandemic
potential of them. However, the factors that promote their replication in mammals remain poorly
understood. Here, we generated mouse-adapted variants of a reassortant H7N1 virus to identify adaptive
changes that confer enhanced virulence in mammals. The mouse lethal doses (MLD50) of the variants
were reduced 410,000-fold compared to the parental virus. Adapted variants displayed enhanced
replication kinetics in vitro and vivo, and were capable of replicating in multiple organs. Analysis of the
variant virus genomes revealed amino acid changes in the PB2 (E627K), HA (H3 numbering; E114K,
G205E, and G218E), and NA (S350N) proteins. Notably, some amino acid changes have been identiﬁed in
natural H7 isolates. Our results implicate a number of amino acid substitutions that collectively enhance
the ability of a wild bird-origin H7N1 AIV to replicate and cause severe disease in mice.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Wild aquatic birds are the natural reservoir of avian inﬂuenza
viruses (AIVs) (Webster et al., 1992). Although AIVs usually
replicate efﬁciently in their natural avian hosts, there are reports
that some AIVs can also infect dogs, cats, plateau pikas, rhesus
macaques, and occasionally humans (Cheng et al., 2014b; Shinya
et al., 2012; Songserm et al., 2006; Yu et al., 2014; Zhang et al., 2013a,
2013b). For example, human infections with a novel H7N9 AIV were
ﬁrst reported in China in 2013, and have been a growing public
health concern (Gao et al., 2013). Notably, some AIVs have the
capacity to transmit between ferrets and guinea pigs, further
suggesting their pandemic potential (Belser et al., 2013; Gao et al.,
2009; Zhang et al., 2013c).
H7N1 viruses circulate worldwide in areas including North
America (Panigrahy et al., 1995) and Europe (Brown, 2010;
Gonzales et al., 2011), as well as southern China (Peng et al.,
2014), Australia (Bulach et al., 2010), and New Zealand (Bulach
et al., 2010). Zoonotic transmission of H7 inﬂuenza viruses to
humans has been suggested by reports of signiﬁcantly elevated
H7-speciﬁc antibody titers among poultry workers in Italy (Di
Trani et al., 2012), and documented H7 AIV infection of humans in
China in 2013 (Gao et al., 2013). A previous report found that an
H7N1 AIV with no history of human infection could become
capable of airborne transmission among ferrets following adaptive
changes introduced by serial passage (Sutton et al., 2014). Taken
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together, sporadic human infections with H7 AIVs, the ability of
adapted H7N1 AIVs to transmit between mammals, and a lack of
pre-existing immunity to H7N1 AIVs in humans suggest that H7N1
AIVs may pose a pandemic threat. In addition, the occurrence of
the novel human H7N9 AIVs, which are low pathogenic avian
inﬂuenza (LPAI) viruses, in 2013 suggested that the risk of H7 LPAI
viruses infection in humans. Therefore, the molecular features
involved in the mammalian adaptation of H7N1 LPAI viruses
should be further studied.
Mice provide an excellent animal model in which to study of
the mammalian adaptation of avian inﬂuenza viruses (Belser et al.,
2013; Belser and Tumpey, 2013; Cheng et al., 2014a; Gabriel et al.,
2005; Hatta et al., 2001; Li et al., 2014, 2005; Song et al., 2009;
Tumpey et al., 2002). To identify changes that are associated with
the adaptation of H7N1 AIV to mammals, we serially passaged a
wild waterfowl-origin H7N1 virus in mice. We hypothesized that
serial passage would allow us to identify molecular determinants
that are important for the adaptation of H7N1 AIVs to mammalian
hosts through the purifying selection of viral variants with
increased ﬁtness. After sequential passage of an H7N1 virus in
mice, we obtained two viruses that displayed enhanced replication
kinetics and increased virulence in vitro and in vivo. Genomic
analysis identiﬁed multiple amino acid substitutions in the
adapted viral variants. These results identify a number of amino
acid substitutions that collectively confer increased virulence,
expanded viral tropism, and enhanced replicative capacity to a
wild bird-origin H7N1 AIV in a mammalian model.
Results
WT H7N1 29Y virus is a reassortant virus
The genomic segments of the WT H7N1 29Y virus were
sequenced and compared to the genomic sequences of other AIVs
available in GenBank. Virus isolates possessing the highest percent
nucleotide identity to each viral gene segment of the 29Y virus
were identiﬁed and revealed that the WT H7N1 29Y virus is likely
a reassortant viruses containing genes from H7N7, H7N1, H6N1,
and H10N9 subtypes (Table 1). Sequence analysis show that the
WT H7N1 29Y virus lacks a polybasic cleavage site in the
hemagglutinin, suggesting that it is a LPAI virus for poultry.
Serial passage generated H7N1 variants that are highly pathogenic in
mice
We compared the pathogenicity of the WT H7N1 29Y virus
with two mouse-adapted variants (named MA-P1P5 or MA-P3P5)
that were produced by independent serial passages of 29Y in mice.
Mice were infected intranasally with 106 EID50 WT 29Y or the
mouse-adapted variant viruses and were followed for 14 days for
body weight loss. A group of mock-infected mice were included as
a control. Mice that lost 425% of their initial body weight were
considered moribund and were euthanized. At an infecting dose of
106 EID50, 60% mice inoculated with WT 29Y survived, and showed
modest body weight loss beginning approximately 3 days post-
infection (Fig. 1A and B). In contrast, mice infected with 106 EID50
of the mouse-adapted MA-P1P5 or MA-P3P5 variants rapidly lost
weight and succumbed to infection by day 3 post-infection (Fig. 1A
and B). We determined that the WT 29Y virus MLD50 was 6.25
log10 EID50, and the MLD50 of the MA-P1P5 and MA-P3P5 viruses
were 2.25 log10 EID50 and 1.75 log10 EID50, respectively (Table 2).
Therefore, serial passage of WT 29Y resulted in substantially
increased virulence in mice.
The mouse-adapted viruses replicate more efﬁciently in MDCK cells
and A549 cells
We next evaluated the replicative ability of the WT 29Y and
mouse-adapted H7N1 strains in MDCK cells (Fig. 2A) and A549
cells (Fig. 2B). In vitro growth kinetics revealed that the MA-P1P5
and MA-P3P5 viruses grew faster and achieved higher titers than
WT 29Y (Fig. 2A and B). MA-P3P5 grew to the highest titer and
yielded approximately 14-fold higher viral titers than WT 29Y in
MDCK cells by 48 h post-inoculation (Fig. 2A). MA-P3P5 grew to
the highest titer and yielded approximately 10-fold higher viral
titers than WT 29Y in A549 cells by 48 h post-inoculation (Fig. 2B).
These data show that the enhanced virulence of the mouse-
adapted H7N1 viruses correlates with increased viral replication
in vitro.
The mouse-adapted H7N1 viruses replicate to higher titers in
respiratory tissues and digestive tracts and acquired the ability to
replicate in multiple organ systems in mice
To determine if the mouse-adapted H7N1 strains also replicate
more efﬁciently than the wild type virus in vivo, we inoculated
mice with 104 EID50 of each virus and analyzed virus titers in the
lungs on day 3 and 5 post-infection (Fig. 2C). Both mouse-adapted
viruses replicated to signiﬁcantly higher titers than WT 29Y in the
lungs at day 3 post-infection, but replicated to levels comparable
to WT 29Y by day 5 post-infection (Fig. 2C). The titers of WT 29Y
were 6.970.4 log10 EID50/g on day 3 post-infection, and 7.770.4
log10 EID50/g on day 5 post-infection, whereas the titers of MA-
P1P5 and MA-P3P5 were 8.570.1 log10 EID50/g and 8.670.2 log10
EID50/g, respectively, on day 3 post-infection, and 7.470.2 log10
EID50/g and 7.970.1 log10 EID50/g on day 5 post-infection (Fig. 2C).
These data show that the enhanced virulence of the mouse-
adapted H7N1 viruses correlates with increased viral replication
in the lungs of mice by 3 days post-infection.
Table 1
Identiﬁcation of viruses harboring gene segments with highest sequence identity to each segment of A/Baer’s Pochard/HuNan/414/2010 (H7N1) using sequence data
available in GenBank.
Genea Virus with the highest percentage of nucleotide identity GenBank accession no. % Identity
PB2 A/mallard/Korea/NHG187/2008(H7N7) KC609821 99
PB1 A/mallard/Sweden/1985/2003(H7N7) CY183342 98
PA A/wild bird/Korea/A330/2009(H7N7) JN244164 99
HA A/ruddy shelduck/Mongolia/921C2/2009(H7N1) KC904723 99
NP A/mallard/Korea/NHG187/2008(H7N7) KC609905 99
NA A/duck/Eastern China/1/2008(H6N1) JF965336 99
M A/northern shoveler/Hong Kong/MPE2531/2008(H10N9) KF259266 99
NS A/duck/Mongolia/867/2002(H7N1) AB473547 99
a PB2, basic polymerase 2; PB1, basic polymerase 1; PA, acidic polymerase; HA, hemagglutinin; NP, nucleoprotein; NA, neuraminidase; M, matrix; NS, nonstructural
protein.
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We then asked whether the increased virulence of the mouse-
adapted H7N1 strains was due to an expansion of the tropism of
the adapted variants. Mice were inoculated intranasally with 106
EID50 WT 29Y, MA-P1P5, or MA-P3P5. On day 3 post-infection, the
lungs, brains, intestines, livers, spleens, and kidneys were collected
and the viral load in each tissue was determined (Fig. 2D). Virus
was recovered from the lungs and intestines of mice inoculated
with WT 29Y, but was not detected in any other organ tested
(Fig. 2D). In contrast, virus from mice inoculated with either
mouse-adapted H7N1 strains were recovered from the lungs and
intestines at higher titers when compared to mice inoculated with
WT 29Y and were also recovered from the brains, livers, spleens,
and kidneys (Fig. 2D). These data demonstrate that the mouse-
adapted H7N1 strains replicated to higher titers in respiratory
tissues and digestive tracts when compared to the WT 29Y virus,
and acquired the ability to replicate to detectable levels in the
brain, liver, spleen, and kidney.
Sequence analysis
We sequenced the genomes of the MA-P1P5 and MA-P3P5
viruses to identify the adaptive mutations responsible for the
increased virulence in mice (Table 3). While sequence analysis
revealed a number of synonymous and nonsynonymous mutations
in the mouse adapted viruses, we focused on mutations that
encoded amino acid substitutions for subsequent analyses. The
MA-P1P5 and MA-P3P5 viruses both had an E-K substitution
at PB2 position 627, a E-K substitution at HA position 122
(H7 numbering; H3 numbering is 114), a G-E substitution at
HA position 214 (H7 numbering; H3 numbering is 205), a G-E
substitution at HA position 227 (H7 numbering; H3 numbering is
218), and a S-N substitution at NA position 350 (Table 3). The
MA-P3P5 virus also had an I-T substitution at PB2 position 615
that was not present in the MA-P1P5 virus (Table 3).
To investigate whether the amino acid changes observed in
mouse-adapted H7N1 strains generated in this study have been
identiﬁed in H7 isolates, we queried H7 sequences deposited in
the GenBank database. We identiﬁed three isolates possessing a T
residue at PB2 position 615, forty-ﬁve isolates possessing a K
residue at PB2 position 627, ﬁve isolates possessing a K residue at
HA position 122 (H7 numbering), thirteen isolates possessing an E
residue at HA position 214 (H7 numbering), and nine isolates
possessing an E residue at HA position 227 (H7 numbering)
(Table 4), and found no evidence of H7 isolates possessing an N
residue at NA position 350. It is worth noting that the E627K
substitution in the PB2 protein is known to play important roles in
the adaptation of avian H5N1 viruses to mammalian hosts, and is
associated with increased replicative capacity and pathogenesis in
humans and mice (Gabriel et al., 2013; Hatta et al., 2001). Our
results suggest that PB2 E627K may also be an important adaptive
change leading to enhanced H7N1 viral virulence in mammals.
Discussion
Considering that the LPAI viruses in poultry also pose severe
threat to human health, as observed in H7N9 viruses (Gao et al.,
2013), the WT H7N1 29Y virus, which is a LPAI virus for poultry, is
used for studying the pathogenesis of AIVs in this research. In this
study, we used mice as a model system for studying the mamma-
lian adaptation of a reassortant H7N1 avian inﬂuenza virus
isolated from wild waterfowl and show that highly pathogenic
variants can quickly emerge from a parental virus during limited
serial passage. These adapted viral variants displayed expanded
tissue tropism and increased replication kinetics in vitro and
in vivo. Sequence analysis of adapted viruses identiﬁed multiple
amino acid substitutions, including a lysine residue at PB2 position
627, that are likely involved in the adaptation of H7N1 avian
inﬂuenza virus in mice.
Serial passage of avian inﬂuenza viruses has been frequently
used to identify adaptive changes that can occur when avian
viruses replicate in mammalian hosts (Gabriel et al., 2013, 2005).
It is becoming increasingly clear that adaptive mutations are
required in order for avian inﬂuenza viruses to efﬁciently replicate
in mammalian hosts (Bussey et al., 2011). The PB2-E627K sub-
stitution has been consistently found to contribute to the adapta-
tion of H5N1 and H7N7 highly pathogenic avian inﬂuenza viruses
in mammals (Gabriel et al., 2005; Hatta et al., 2001). It is still
unclear how PB2 E627K mutation changes viral pathogenicity in
mammals, although the difference in surface charge of the 627E-
or 627K-containing domain of PB2 may affect PB2 interactions
with other viral or cellular proteins (Kuzuhara et al., 2009). While
the PB2 E627K substitution has been reported to confer increased
virulence in mammals in the context of other avian inﬂuenza
Table 2
MLD50 of wild-type 29Y H7N1 virus and mouse-
adapted H7N1 variants in BALB/c mice.
Virusa MLD50 (log10 EID50)
WT 29Y 6.25
MA-P1P5 2.25
MA-P3P5 1.75
a WT 29Y, A/Baer’s Pochard/HuNan/414/2010
(H7N1); MA-P1P5, mouse-adapted 29Y; MA-P3P5,
mouse-adapted 29Y.
Fig. 1. Increased virulence of mouse-adapted H7N1 virus in mice. Mice (n¼5) were
inoculated intranasally with 50 μl containing 106 EID50 of mouse-adapted isolates
(MA-P1P5 and MA-P3P5) or the parental wild-type H7N1 virus (WT) or mock
inoculated (Mock; n¼5), and animals that lost more than 25% of their pre-infection
weight were euthanized. (A) Morbidity was examined by recording the body
weights of inoculated mice daily, and it is represented as a percentage of the weight
on the day of inoculation (day 0). The average of each group is shown. The
proportion of surviving mice in each group is indicated. (B) Mouse mortality after
inoculation with 50 μl containing 106 EID50 of mouse-adapted isolates (MA-P1P5
and MA-P3P5) or the parental wild-type H7N1 virus (WT) or diluent (Mock).
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subtypes, it has not been experimentally investigated for H7N1
subtype avian inﬂuenza viruses. In this report, we provide data to
suggest that the PB2-E627K contributes to the highly virulent
phenotype of mouse-adapted H7N1 viral variants. Multiple studies
have linked amino acid substitutions in the HA protein of inﬂuenza
viruses with enhanced mouse infectivity and virulence (Uraki
et al., 2013; Watanabe et al., 2013). In our study, three HA amino
acid substitutions ((H3 numbering; E114K, G205E, and G218E)
were identiﬁed in two independently generated mouse-adapted
variant viruses, suggesting that these adaptive changes may
contribute to the enhancement of virulence of H7N1 AIV in mice.
Differences in protease sensitivity of HA is an important determi-
nant for systemic spread of infection (Bottcher-Friebertshauser et
al., 2014), suggesting that these HA mutations found in our study
may contribute to the expanded tissue tropism of these adapted
H7N1 variants. Interestingly, the HA-G218E was also identiﬁed in
the mouse-adapted human H3N2 inﬂuenza virus which exhibited
high virulence in a previous report (Narasaraju et al., 2009).
Fig. 2. Growth characteristics of mouse-adapted H7N1 viruses in vitro and vivo. (A) MDCK cells were inoculated at a multiplicity of infection of 0.01 TCID50/cell with the
parental wild-type H7N1 virus (WT) or a mouse-adapted virus (MA-P1P5 or MA-P3P5). Supernatants were collected at the indicated time points and titrated in MDCK cells
by TCID50. (B) A549 cells were inoculated at a multiplicity of infection of 0.01 TCID50/cell with the parental wild-type H7N1 virus (WT) or a mouse-adapted virus (MA-P1P5
or MA-P3P5). Supernatants were collected at the indicated time points and titrated in MDCK cells by TCID50. (C) Mice (n¼3) were inoculated intranasally with 104 EID50 of
the parental wild-type H7N1 virus (WT) or a mouse-adapted virus (MA-P1P5 or MA-P3P5). Viral loads in the lungs were determined at 3 and 5 days post-infection in eggs by
EID50. Results are expressed as log10 EID50/g of tissue. The dotted line indicates the limit of detection. (D) Mice (n¼3) were infected with 106 EID50 of the parental wild-type
H7N1 virus (WT) or a mouse-adapted virus (MA-P1P5 or MA-P3P5). On day 3 post-infection, viral loads in the lungs, brains, intestines, livers, spleens, and kidneys were
titrated in eggs by EID50. Results are expressed as log10 EID50/g of tissue. The dotted indicates the lower limit of detection of infectious virus. In each panel, the average of
three replicates is shown with error bars indicating the standard deviation. n, 1po0.05, when comparing MA-P1P5 and MA-P3P5 with WT respectively, as determined by
two-way ANOVA. nn, 11po0.01, when comparing MA-P1P5 and MA-P3P5 with WT respectively, as determined by two-way ANOVA. nnn, 111po0.001, when comparing MA-
P1P5 and MA-P3P5 with WT respectively, as determined by two-way ANOVA.
Table 3
Nucleotide and amino acid substitutions identiﬁed in mouse-adapted H7N1 avian
inﬂuenza viruses.
Segment Nucleotide
position
Nucleotide
mutation
Amino acid
position
Amino acid
substitution
Mouse-
adapted
virus
PB2 1844 T-C 615 I-T MA-P3P5
1879 G-A 627 E-K MA-P1P5
MA-P3P5
PA 1077 C-T 359 – MA-P3P5
HA 364 G-A 122a (114b) E-K MA-P1P5
MA-P3P5
432 C-T 144a (136b) –c MA-P1P5
MA-P3P5
641 G-A 214a (205a) G-E MA-P1P5
MA-P3P5
680 G-A 227a (218b) G-E MA-P1P5
MA-P3P5
1200 R-A 400a (390b) – MA-P3P5
NP 1260 C-T 420 – MA-P1P5
MA-P3P5
NA 1049 G-A 350 S-N MA-P1P5
MA-P3P5
1116 C-T 372 MA-P3P5
a H7 numbering.
b H3 numbering.
c Synonymous mutation.
Table 4
Web search for the amino acid changes observed in mouse-adapted H7N1 strains
generated in this study have been identiﬁed in H7 subtype isolates.
Segment Position Amino acid Frequency of substitution (no. of strains
with the substitution/total no. of strains)
PB2 615 T 3/1469
627 K 45/1469
HA 122 K 5/1951
214 E 13/1951
227 E 9/1951
NA 350 N 0/1571
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Importantly, many of the amino acid changes identiﬁed in the
mouse-adapted H7N1 viruses have been identiﬁed in H7N1 iso-
lates collected from various avian species (Table 4).
In conclusion, we identiﬁed multiple amino acid substitutions
that collectively enhance H7N1 AIV virulence in a mouse model.
Our ﬁndings showed that increased H7N1 virulence was asso-
ciated with accelerated viral growth in mammalian cells and
expanded tissue tropism in vivo. Additional studies will be
required to study the impact of each of these adaptive changes
on viral virulence in mice. Mouse passage experiments are a way
to identify adaptive changes that contribute to viral pathogenicity
in mice. However, these changes may not have similar effects in
other mammalian species. Human seasonal viruses, for example,
are already well adapted to mammals, but often mutate to become
more pathogenic in mice after passage in these animals. Therefore,
extension of these ﬁndings to other animal models, such as ferrets
and macaques, will be needed to better understand the mechan-
isms of mammalian adaptation and interspecies transmission of
H7N1 AIVs and assess the impact of these amino acid substitutions
on H7N1 infection of humans.
Materials and methods
Facilities
Studies with H7N1 AIV and the variants were conducted in a
biosecurity level 3 laboratory approved by the Military Veterinary
Research Institute of the Academy of Military Medical Sciences. All
animal studies were approved by the Review Board of Military
Veterinary Research Institute of the Academy of Military Medical
Sciences.
Cells and virus
Madin–Darby canine kidney (MDCK) cells were cultured in
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
2 mM glutamine, 5% fetal calf serum (FCS), 100 IU/ml penicillin,
and 100 mg/ml streptomycin. A549 cells were cultured in DMEM
supplemented with 2 mM glutamine, 10% FCS, 100 IU/ml penicillin,
and 100 mg/ml streptomycin. The H7N1 virus A/Baer’s Pochard/
HuNan/414/2010 (H7N1) (abbreviated as 29Y), was isolated from a
Baer’s Pochard in Hunan province, China. Stock viruses were
grown in the allantoic cavities of 10-day-old chicken eggs for
48 h at 37 1C, and aliquots were stored at 80 1C until used. The
GenBank accession numbers corresponding to each of the eight
29Y viral gene segments are JQ973643-JQ973650.
Adaptation of H7N1 inﬂuenza virus in mice
Two mouse-adapted variants of the 29Y virus were derived
from two independent series of sequential lung-to-lung passages
of virus in mice as described previously (Brown, 1990). Brieﬂy,
female 3–5-week-old BALB/c mice (Merial-Vital Laboratory Animal
Technology Co., Ltd., Beijing, China) were inoculated intranasally
with 50 μl of allantoic ﬂuid containing the wild type (WT) 29Y
H7N1 virus under light isoﬂurane anesthesia. Lungs were har-
vested and homogenized 48 h after infection. The disrupted lung
tissue was centrifuged to remove debris and 50 μl of the super-
natant was used to inoculate the next naïve mouse in the series.
Virus was passaged mouse-to-mouse ﬁve times in two indepen-
dent lines. After the ﬁfth passage in each series of mice, viruses
present in the ﬁnal lung homogenates were cloned once by plaque
puriﬁcation in MDCK cells as described previously (Song et al.,
2009). The plaque-puriﬁed viruses were independently ampliﬁed
in the allantoic cavities of 10-day-old chicken eggs for 48 h at 37 1C
to prepare virus stocks. Two plaque-puriﬁed mouse-adapted
variants of the original 29Y virus were obtained for further
characterization and named MA-P1P5 and MA-P3P5.
Virus titration in eggs and MDCK cells
Virus titers in virus stocks and homogenized organ samples
were determined by end-point titration in eggs and/or MDCK cells.
For end-point viral titration in eggs, ten-fold serial dilutions of
each sample were inoculated into eggs. Forty-eight hours after
inoculation, ﬂuid from the allantoic cavity was collected and tested
for the ability to agglutinate chicken erythrocytes as an indicator
of virus replication. Infectious virus titers were reported as log10
EID50/ml or log10 EID50/g, and were calculated from 3 replicates by
the method of Reed and Muench (1938). For end-point viral
titration on MDCK cells, ten-fold serial dilutions of each sample
were inoculated onto MDCK cell monolayers grown in a 96 well
culture plate. One hour after inoculation, the monolayer was
washed with phosphate-buffered saline (PBS), and cultured in
100 ml of DMEM supplemented with 100 IU/ml penicillin, and
100 mg/ml streptomycin, 2 mM glutamine, and 2 mg/ml TPCK-
treated trypsin. Seventy-two hours after inoculation, supernatants
of infected cell cultures were tested for agglutinating activity using
chicken erythrocytes as an indicator of virus replication. Infectious
virus titers were calculated from 3 replicates by the method of
Reed and Muench (1938), and expressed as log10 TCID50 (50%
tissue culture infectious dose)/ml.
In vivo experiments
The 50% mouse lethal dose (MLD50) of the parental 29Y virus
and the two mouse-adapted isolates was measured using groups
of three female 4–5-week-old BALB/c mice (Merial-Vital Labora-
tory Animal Technology Co., Ltd., Beijing, China). Mice were
intranasally inoculated with 50 μl of 10-fold serial dilutions of
each indicated inﬂuenza virus in PBS under isoﬂurane sedation,
with doses ranging from 101 to 106 EID50. Survival and body
weight changes were recorded daily for 14 days post-infection
(dpi). Animals that showed signs of severe disease and weight loss
425% of their initial body weight were considered moribund and
were humanely sacriﬁced. MLD50 values were calculated by the
Reed and Muench (1938) method after a 14-day observation
period and expressed as EID50.
Mice were additionally intranasally inoculated with 104 EID50 of
the indicated viruses to measure the replicative capacity of mouse-
adapted isolates as compared to the parental 29Y virus in the lungs.
Three mice in each group were euthanized at 3 and 5 dpi. The lungs
were collected, homogenized, and tissue debris was removed by low-
speed centrifugation. Virus titers of each sample were determined by
endpoint titration in eggs as described above, and virus titers of each
strain were expressed as mean log10 EID50/g7standard deviation
(SD). To evaluate the tropism and replication capacity of each virus
in vivo, we euthanized three mice on 3 days after inoculation with
106 EID50 29Y or mouse-adapted isolates and harvested the lungs,
brains, intestines, livers, spleens, and kidneys. Organs were homo-
genized in 1 ml of PBS and viral titers in each of the organs were
determined by titration in chicken eggs. Titers were calculated by the
Reed and Muench (1938) method and expressed as mean log10
EID50/g7SD. The limit of virus detection was 0.75 log10 EID50/g. For
calculation of the mean, samples with a virus titer of o0.75 log10
EID50/g were assigned a value of 0.
Analysis of replication kinetics in MDCK cells and A549 cells
MDCK cells and A549 cells were infected with indicated
inﬂuenza viruses at a multiplicity of infection (MOI) of 0.01
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TCID50/cell. After incubation, the cells were washed and overlaid
with DMEM containing 2 mg/ml TPCK-treated trypsin. Superna-
tants were collected 12, 24, 36, 48, 60, and 72 h after infection and
stored at 80 1C. Virus titer was determined by end-point titra-
tion in MDCK cells. Virus titers of each virus in different time point
were expressed as mean log10 TCID50/ml7SD.
RNA isolation, PCR ampliﬁcation, and sequencing
Viral RNA was isolated from the allantoic ﬂuid of inoculated
eggs using the RNeasy Mini kit (QIAGEN, Germantown, MD)
according to the manufacturer’s protocol. Reverse transcription
of viral RNA and subsequent PCR were performed using primers
speciﬁc for each gene segment (sequences available upon request).
PCR products were puriﬁed using the QIAquick PCR puriﬁcation kit
(QIAGEN, Germantown, MD) according to the manufacturer’s
protocol. Viral gene segments were sequenced by the Beijing
Genomics Institute (Beijing, China). Sanger sequencing methodol-
ogy was used to sequence the PCR-ampliﬁed viral gene segments.
DNA sequences were analyzed and compared to the parental 29Y
virus using the Lasergene sequence analysis software package
(DNASTAR, Madison, WI).
Statistical analysis
Data were analyzed by two-way analysis of variance using
GraphPad Prism version 5.00 (GraphPad Software, San Diego, CA,
USA). When a signiﬁcant effect was observed, pairwise compar-
isons were performed using the Bonferroni post-hoc test.
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